KidsCancerKinome was an European project funded by the European Commission through the 6th Framework Programme for Research and Development. It aims at selecting and validating drug targets from the human kinome for high risk paediatric cancers.
KidsKancerKinome was a joined project of the 9 ITCC research laboratories, an SME focused on drug development (Santaris Pharmaceutics) and a French SME skilled in administrative and financial management of FP projects. The project began in November 1st 2006 and lasted 42 months.
Please find an accurate summary of the project: